2005
DOI: 10.1016/j.hrthm.2005.08.024
|View full text |Cite
|
Sign up to set email alerts
|

Syndactyly and long QT syndrome (CaV1.2 missense mutation G406R) is associated with hypertrophic cardiomyopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(17 citation statements)
references
References 11 publications
1
16
0
Order By: Relevance
“…4C). The simulations are consistent with the observation that 100% of the TS mutation carrier exhibits QT interval prolongation (22,41,42).…”
Section: Resultssupporting
confidence: 88%
See 1 more Smart Citation
“…4C). The simulations are consistent with the observation that 100% of the TS mutation carrier exhibits QT interval prolongation (22,41,42).…”
Section: Resultssupporting
confidence: 88%
“…In the clinical studies (22,41,42), extreme T-wave alternans (with an inversion on opposite beats) is observed in TS patients with a heart rate of 120 beats/min (an example is shown in Fig. 6E, which was reproduced from Ref.…”
Section: Resultsmentioning
confidence: 68%
“…Additional cardinal features of TS include: bradycardia, AV-Block, congenital heart disease, immune deficiency, hypoglycemia, neurological and cognitive abnormalities such as intellectual disability, autism and seizures as well as distinctive cranio-facial abnormalities. Also, an association of TS with hypertrophic cardiomyopathy has been described [7]. …”
Section: Introductionmentioning
confidence: 99%
“…Fetal hydrops is considered as obligated consequence of heart failure by sustained episodes of fetal AV dissociation and ventricular arrhythmia [Ishikawa et al, 2013]. A genetic explanation for this prenatal presentation of TS1 is difficult because our propositus and the patient of Lo-A-Njoe et al (2005, patient B) shared the same Ca V 1.2 mutation, as in the others previous patients with proven TS1at the molecular level [Lo-A-Njoe et al, 2005;Splawski et al 2006], but without hydrops. Prenatal drugs could affect the QTc interval of the fetus [Kies et al, 2005], and such exposure could be contributor for fetal hydrops in our patient in relation with the referred use of amitriptyline during the first 4 months of pregnancy, since this tricyclic antidepressant is associated with a significant increase in the QTc interval [van Noord et al, 2009].…”
Section: Discussionmentioning
confidence: 64%